Iris Acquisition Corp
Status: Closed Deal
U=S+W/4 W=S@11.5
IPO Proceeds, $M $276.00M
IPO Date Mar 5, 2021
CEO Sumit Mehta
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24 + 6 + 6 + 6 + 3 + 3
IPO Sector General
IPO Geography Global
Target Company Liminatus Pharma
Deal Announced Nov 30, 2022
Deal Size, $M $175.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Mar 4, 2025
Amendment Vote Dec 20, 2024
Closing Date Apr 30, 2025
Formerly IRAA LIMN LIMNW

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.